Theravance Poised to Jump
Minyanville.com The drug, Relovair, is being tested as a once-daily treatment for chronic obstructive pulmonary disease and asthma. Glaxo sees it as a successor to Advair, … |
View full post on asthma – Google News
Theravance Poised to Jump
Minyanville.com The drug, Relovair, is being tested as a once-daily treatment for chronic obstructive pulmonary disease and asthma. Glaxo sees it as a successor to Advair, … |
View full post on asthma – Google News